CVS Health Corporation entered into an underwriting agreement to issue $4 billion in aggregate principal amount of senior notes across four maturities: $750 million due 2032, $1.5 billion due 2035, $1.25 billion due 2055, and $500 million due 2065. The company expects net proceeds of approximately $3.96 billion from the sale.
